Stock Information
  Corporate Presentation
  Financial News
  Earnings Estimate
  Media Kit
  Analyst Coverage
  Financial Reports
  SEC Filings
  Event Calendar
  FAQs
  E-mail Alerts
  Information Request





This information is part of the archives and is no longer current and may no longer be accurate.

Receive E-mail AlertsE-mail Alerts
Keyword Search
 
2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004
DateTitle 
05/03/12DURECT Announces Issuance of U.S. Patents Covering ORADUR® TechnologyPrinter Friendly Version
05/03/12DURECT Corporation Announces First Quarter 2012 Financial Results and Update of ProgramsPrinter Friendly Version
04/25/12DURECT Corporation Invites You to Join its First Quarter 2012 Earnings Conference CallPrinter Friendly Version
03/29/12DURECT Receives Back U.S. and Canadian Product Rights to POSIDUR™Printer Friendly Version
03/01/12DURECT Corporation Announces Fourth Quarter and Year End 2011 Financial ResultsPrinter Friendly Version
02/24/12DURECT Corporation Invites You to Join Its Fourth Quarter 2011 Earnings Conference CallPrinter Friendly Version
02/23/12DURECT to Participate in Upcoming Healthcare ConferencesPrinter Friendly Version
02/07/12DURECT to Present at the BIO CEO & Investor ConferencePrinter Friendly Version
01/30/12DURECT Receives Back European Product Rights to POSIDUR™Printer Friendly Version
01/05/12DURECT Announces Top-line Data from BESST (POSIDUR® U.S. Pivotal Phase III Trial)Printer Friendly Version




© 2000-2012 DURECT Corporation
Last updated: September 20, 2011
Search    Contact    Site Index    Legal Notice    Privacy Policy